Corcept Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $256,147 | $164,903 | $202,125 | $207,638 |
Gross Profit | 252,086 | 162,020 | 199,580 | 203,042 |
EBITDA | 46,794 | -44,117 | 10,392 | 15,720 |
EBIT | 45,931 | -44,715 | 9,910 | 15,243 |
Net Income | 42,141 | -31,202 | 24,288 | 19,668 |
Net Change In Cash | 256,147 | 164,903 | 202,125 | 207,638 |
Free Cash Flow | 31,015 | -16,973 | 38,398 | 54,481 |
Cash | 111,039 | 108,738 | 120,495 | 125,138 |
Basic Shares | 118,385 | 104,435 | 119,855 | 119,439 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $761,407 | $675,040 | $482,375 | $401,858 |
Gross Profit | 748,430 | 664,158 | 475,894 | 396,473 |
EBITDA | 68,352 | 162,829 | 125,599 | 115,603 |
EBIT | 66,462 | 161,493 | 124,557 | 112,634 |
Net Income | 99,652 | 139,733 | 106,140 | 101,418 |
Net Change In Cash | 761,407 | 675,040 | 482,375 | 401,858 |
Free Cash Flow | 141,785 | 195,895 | 126,900 | 119,910 |
Cash | 120,495 | 127,665 | 135,551 | 66,329 |
Basic Shares | 119,987 | 113,480 | 111,742 | 115,966 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $0.36 |
2026-03-31 | -$0.30 |
2025-12-31 | $0.20 |
2025-09-30 | $0.16 |